Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...
CyGenica Limited has developed a new class of engineered cell-penetrating protein as a drug delivery system, creating a drilling mechanism which can penetrate target cell membranes and safely ...
Researchers have come up with a novel tool that can develop new thiophosphate-based nucleotide drugs specifically targeting genetic molecules. A recent UN panel has been formed to look into the ...